Drug Profile
Research programme: small molecules - Zosano Pharma
Alternative Names: Epinephrine transdermal - Zosano Pharma; Fentanyl - Zosano Pharma; Granisetron - Zosano Pharma; Naratriptan - Zosano Pharma; Pentosan polysulfate - Zosano Pharma; Sumatriptan - Zosano Pharma; Zolmitriptan - Zosano PharmaLatest Information Update: 18 Sep 2023
Price :
$50
*
At a glance
- Originator Zosano Pharma
- Class Analgesics; Antiemetics; Antimigraines; Antithrombotics; Small molecules
- Mechanism of Action 5-HT1 serotonin receptor agonists; Adrenergic receptor agonists; Cell membrane structure inhibitors; Opioid mu receptor agonists; Serotonin 1B receptor agonists; Serotonin 1D receptor agonists; Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Anaphylaxis; Chemotherapy-induced nausea and vomiting; Interstitial cystitis; Migraine; Pain; Thrombosis
Most Recent Events
- 18 Sep 2023 Discontinued - Preclinical for Anaphylaxis in USA (Transdermal)
- 18 Sep 2023 Discontinued - Preclinical for Chemotherapy-induced nausea and vomiting in USA (Transdermal)
- 18 Sep 2023 Discontinued - Preclinical for Interstitial cystitis in USA (Transdermal)